CYCN Cyclerion Therapeutics, Inc.
Partial data23.52USD-20.94%Mkt Cap: 15.73M $P/E: —30d ago
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periph…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap15.73M USD
Enterprise Value14.09M USD
Revenue (TTM)1.90M USD
Gross Profit303.00K USD
Net Income (TTM)-3.53M USD
Revenue/Share3.43 USD
Last Price23.52 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-17.95
PEG—
EV/EBITDA—
EV/Revenue7.42
P/S8.28
P/B2.81
EPS (TTM)-11.62
EPS (Forward)-1.31
52W Range
1.027100% of range8.480
52W High8.480 USD
52W Low1.027 USD
Profitability
Gross Margin15.95%
Oper. Margin-359.16%
EBITDA Margin0.00%
Profit Margin-170.11%
ROE-38.83%
ROA-35.33%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.31M USD
CapEx (TTM)—
FCF Margin-109.21%
FCF Yield-13.19%
Net Debt-1.39M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.82
Quick Ratio0.76
Book Value/Sh8.37 USD
Cash/Share2.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:7
Split DateSep 9, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.668.76K
Float168.03K
Insiders—
Institutions—
Short Interest
Short Ratio2.2d
Short % Float1.33%
Short % Out.1.12%
Shares Short7.48K
Short (prev mo.)4.97K
Technical
SMA 5026.37 (-10.8%)
SMA 20018.35 (+28.2%)
Beta1.75
S&P 52W Chg13.94%
Avg Vol (30d)57.42K
Avg Vol (10d)21.30K
Technical Indicators
RSI (14)42.1
MACD0.1503
MACD Signal0.1634
MACD Hist.-0.0130
BB Upper4.683 USD
BB Middle3.907 USD
BB Lower3.131 USD
BB Width39.74%
ATR (14)0.4950 USD
Vol Ratio (20d)7.74x